SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-017841
Filing Date
2017-08-18
Accepted
2017-08-18 16:30:29
Documents
4
Period of Report
2017-08-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20170818.htm 8-K 36773
2 EX-5.1 - LEGAL OPINION sbph-ex51_7.htm EX-5.1 15294
3 EX-10.1 - SALES AGREEMENT sbph-ex101_6.htm EX-10.1 325334
4 GRAPHIC g2017081814044184512782.jpg GRAPHIC 134172
  Complete submission text file 0001564590-17-017841.txt   563187
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 171041366
SIC: 2834 Pharmaceutical Preparations